/wp-content/uploads/2019/11/logo_white.png00webadmin/wp-content/uploads/2019/11/logo_white.pngwebadmin2008-12-02 12:51:592016-11-28 12:52:25SuperGen to Present Data at the 50th ASH Annual Meeting & Exposition
/wp-content/uploads/2019/11/logo_white.png00webadmin/wp-content/uploads/2019/11/logo_white.pngwebadmin2008-12-01 12:52:342016-11-28 12:52:57Astex presents updates on AT7519 and AT9283 at the American Society of Hematology (ASH) Conference
/wp-content/uploads/2019/11/logo_white.png00webadmin/wp-content/uploads/2019/11/logo_white.pngwebadmin2008-11-20 12:53:072016-11-28 12:53:41SuperGen Receives Clearance to Begin Clinical Trials With SGI-1776, a PIM Inhibitor
/wp-content/uploads/2019/11/logo_white.png00webadmin/wp-content/uploads/2019/11/logo_white.pngwebadmin2008-10-23 12:55:182016-11-28 12:55:40SuperGen’s MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy
/wp-content/uploads/2019/11/logo_white.png00webadmin/wp-content/uploads/2019/11/logo_white.pngwebadmin2008-10-15 12:55:492016-11-28 12:56:10SuperGen to Present Data at EORTC-NCI-AACR
/wp-content/uploads/2019/11/logo_white.png00webadmin/wp-content/uploads/2019/11/logo_white.pngwebadmin2008-09-29 12:56:182016-11-28 12:56:42Cancer Research UK and Astex Therapeutics Join Forces to Develop New Anti-Cancer Treatment
/wp-content/uploads/2019/11/logo_white.png00webadmin/wp-content/uploads/2019/11/logo_white.pngwebadmin2008-08-07 12:56:522016-11-28 12:57:13SuperGen Granted Orphan Drug Designation for MP-470 in Glioblastoma Multiforme
